MedWatch

Pharmacosmos settles legal dispute with Vifor

Pharmacosmos is now withdrawing the press release that the Danish Medicines Agency has ruled was in breach of the Danish Medicines Act. The ruling was the root of the subsequent case which competitor Vifor brought against the company in the Maritime and Commercial High Court of Denmark.

Photo: Pharmacosmos / PR

Approximately two years have passed since the conflict between the Danish company Pharmacosmos and Vifor Pharma, which is based in Switzerland, began over a phosphare study. The conflict is now solved in a settlement in the Maritime and Commercial High Court of Denmark.

Vifor Pharma, which like the Danish company produces medicines for the treatment of iron deficiency anaemia, originally brought the suit against Pharmacosmos after the Danish Medicines Agency judged a press release concerning the study's findings to be in breach of the Danish Medicines Act.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs